| Latest Accelrys News Headlines | | Date | Time | Source | | | 07/11/2008 | 10:20AM | PRNUS | [video] Stocks Covered on This Week's Episode of WallSt.net's News Magazine: CPWR, CXP, ACCL, GBLE, SDEV, VSHD
NEW YORK, July 11 /PRNewswire/ -- WallSt.net's News Magazine is a half-hour television program that is scheduled to air on Sundays at 5:30 p.m. EDT (2:30 p.m. PDT) on the Fox Business Network.
The show features compelling interviews with public company CEOs, informative trading strategies from investment professionals... More...>> |
| 07/01/2008 | 7:00AM | PRNUS | [video] WallSt.net's '3 Minute Press Show' Features Executive Interviews and Highlights Recent Press for the Following: ACCL, EN
NEW YORK, July 1 /PRNewswire-FirstCall/ -- WallSt.net's 3-Minute Press Show is a daily video program hosted by WallSt.net reporter, Tracee Tolentino.
Shows air Monday through Friday on: http://tv.wallst.net/.
WallSt.net's 3-Minute Press Show features in-depth interviews with public company executives on their company... More...>> |
| 11/15/2005 | 11:43AM | PRNUS | Altair Engineering(R) and Accelrys(R) Integrate Technologies for Materials Sciences Community
New relationship provides Altair PBS Professional(TM) workload management solution within Accelrys Materials Studio(R)
TROY, Mich., Nov. 15 /PRNewswire/ -- Altair Engineering, Inc., a global leader in innovative product development, advanced engineering software and grid computing technology, announced today a cooperative... More...>> |
| 03/14/2005 | 8:01AM | PRNUS | ACCL: Newbridge Securities Initiates Coverage on Accelrys (ACCL) With a Buy Rating and $9 Price Target
ACCL: Newbridge Securities Initiates Coverage on Accelrys (ACCL)
With a Buy Rating and $9 Price Target
FORT LAUDERDALE, Fla., March 14 /PRNewswire/ -- J. Andrew Braswell, equity
analyst with Newbridge Securities Corporation ("Newbridge"), has initiated
coverage on Accelrys, Inc. (NASDAQ:ACCL), with a "Buy" rating and... More...>> |
| 12/17/2004 | 10:00AM | PRNUS | Enexity's Remote Support Solution Chosen By Accelrys
Enexity's Remote Support Solution Chosen By Accelrys
AUSTIN, Texas, Dec. 17 /PRNewswire/ -- Enexity, a leading provider of remote
support solutions, announced today that Accelrys, Inc. (NASDAQ:ACCL), a leading
provider of software for computation, simulation, and the management of
scientific data is using SecureLink... More...>> |
| 12/08/2004 | 11:48AM | PRNUS | Winners of 2004 Life Science Industry Awards
Winners of 2004 Life Science Industry Awards
ARLINGTON, Va., Dec. 8 /PRNewswire/ -- Nearly 200 life science executives
gathered Monday night at the Renaissance Washington, D.C. Hotel for the Life
Science Industry Awards, which were presented by Ira Flatow, host and Executive
Producer of National Public Radio's Science... More...>> |
| 09/29/2004 | 6:35PM | PRNUS | Accelrys to Integrate Sigma-Aldrich Chemical Compound Catalogs Into Cheminformatics Database
Accelrys to Integrate Sigma-Aldrich Chemical Compound Catalogs
Into Cheminformatics Database
Desktop Tool Will Connect Accelrys Chemical Searching Technologies With Online
Supplier Catalogs, Streamlines and Speeds Chemical Purchasing
SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- Accelrys, Inc. (NASDAQ:ACCL)
announced... More...>> |
| 07/07/2004 | 6:52PM | PRNUS | Accelrys Announces Date of First Quarter, Fiscal 2005 Financial Results and Conference Call
Accelrys Announces Date of First Quarter, Fiscal 2005 Financial
Results and Conference Call
SAN DIEGO, July 7 /PRNewswire-FirstCall/ -- Accelrys, Inc. (NASDAQ:ACCL) today
announced that it plans to release its financial results for the quarter ended
June 30, 2004 after the NASDAQ Market closes on Thursday July 29, 2004... More...>> |
| 05/04/2004 | 8:58AM | PRNUS | Pharmacopeia and Pharmacopeia Drug Discovery Announce March 2004 Quarter Financial Results
Pharmacopeia and Pharmacopeia Drug Discovery Announce March 2004
Quarter Financial Results
Operating Cash Flow Improved in Spite of Lower Revenues
SAN DIEGO, May 4 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. and
Pharmacopeia Drug Discovery, Inc. today announced consolidated results for the
quarter ended March 31... More...>> |
| 05/04/2004 | 7:45AM | PRNUS | Pharmacopeia Announces Date of March 2004 Quarter Financial Results Release and Conference Call
Pharmacopeia Announces Date of March 2004 Quarter Financial
Results Release and Conference Call
SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. today
announced that it plans to release its financial results for the quarter ended
March 31, 2004 before the Nasdaq Market opens on Tuesday, May 4, 2004... More...>> |
| 05/03/2004 | 8:02AM | PRNUS | Pharmacopeia Completes Spin-Off of Pharmacopeia Drug Discovery
Pharmacopeia Completes Spin-Off of Pharmacopeia Drug Discovery
PRINCETON, N.J. and SAN DIEGO, May 3 /PRNewswire-FirstCall/ -- Pharmacopeia,
Inc. and Pharmacopeia Drug Discovery, Inc. ("PDD") today announced the
completion of the spin-off of PDD, Pharmacopeia's drug discovery business, into
an independent, separately... More...>> |
| 04/29/2004 | 1:55PM | PRNUS | Pharmacopeia Announces Date of March 2004 Quarter Financial Results Release and Conference Call
Pharmacopeia Announces Date of March 2004 Quarter Financial
Results Release and Conference Call
SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. today
announced that it plans to release its financial results for the quarter ended
March 31, 2004 before the Nasdaq Market opens on Tuesday, May 4, 2004... More...>> |
| 04/19/2004 | 4:38PM | PRNUS | Pharmacopeia Announces Effectiveness of Form 10 Registration Statement of Pharmacopeia Drug Discovery
Pharmacopeia Announces Effectiveness of Form 10 Registration
Statement of Pharmacopeia Drug Discovery
PRINCETON, N.J., April 19 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. today
announced that the Securities and Exchange Commission has declared the
registration statement on Form 10 of Pharmacopeia Drug Discovery... More...>> |
| 04/14/2004 | 4:32PM | PRNUS | Pharmacopeia Declares Dividend to Effect Spin-Off of Pharmacopeia Drug Discovery
Pharmacopeia Declares Dividend to Effect Spin-Off of Pharmacopeia
Drug Discovery
PRINCETON, N.J., April 14 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. today
announced that its Board of Directors declared a dividend of all of the
outstanding shares of common stock of Pharmacopeia Drug Discovery, Inc. (PDD),
the drug... More...>> |
| 04/12/2004 | 12:29PM | PRNUS | fqubed Concludes Technology Licensing Agreement with Pharmacopeia
fqubed Concludes Technology Licensing Agreement with Pharmacopeia
SAN DIEGO, April 12 /PRNewswire/ -- fqubed today announced execution of a
license contract with Pharmacopeia Inc. . Under the terms of the agreement
fqubed has been granted a worldwide license, exclusive in fqubed's areas of
business interest, to the... More...>> |
| 04/07/2004 | 4:27PM | PRNUS | Pharmacopeia Announces Update on Timing of Proposed `Spin-Off' of Pharmacopeia Drug Discovery
Pharmacopeia Announces Update on Timing of Proposed `Spin-Off' of
Pharmacopeia Drug Discovery
Company Also Comments on First Quarter 2004, and Provides Full-Year Financial
Guidance
PRINCETON, N.J., April 7 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. today
announced that the proposed spin-off of its Pharmacopeia Drug... More...>> |
| 03/23/2004 | 8:08AM | PRNUS | Pharmacopeia Extends and Expands Research Collaboration With Celgene
Pharmacopeia Extends and Expands Research Collaboration With Celgene
PRINCETON, N.J., March 23 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. today
announced that it has extended and expanded its research collaboration with
Celgene Corporation, following on from the successful collaboration between the
corporations that... More...>> |
| 03/09/2004 | 4:35PM | PRNUS | Pharmacopeia Collaboration With Schering-Plough Results in Initiation of Human Trials for Inflammatory Indication
Pharmacopeia Collaboration With Schering-Plough Results in Initiation of Human
Trials for Inflammatory Indication
Second Clinical Trial Milestone with Schering-Plough
PRINCETON, N.J., March 9 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc.
announced today that Schering-Plough Corporation has initiated human trials of
a... More...>> |
| 03/04/2004 | 3:54PM | PRNUS | Pharmacopeia Chairman and CEO to Present at SG Cowen's 24th Annual Health Care Conference On March 10, 2004
Pharmacopeia Chairman and CEO to Present at SG Cowen's 24th Annual Health Care
Conference On March 10, 2004
PRINCETON, N.J., March 4 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. today
announced that Dr. Joseph A. Mollica, Chairman, President and CEO, will present
at the SG Cowen 24th Annual Health Care Conference at... More...>> |
|